alexa Editor - Zakaria Abd Elmageed | Tulane University | 20270

Journal of Prostate Cancer
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Zakaria Abd Elmageed

Zakaria Abd Elmageed
Zakaria Abd Elmageed
Department of Urology
Tulane University
United States
Tulane University

Biography

Dr. Abd Elmageed did his postdoctoral training in cell and molecular biology of cancer disease at three major medical schools: Louisiana State University, Johns Hopkins University, and Tulane University. At each institution, he sought to improve his research and pursued cutting-edge research in basic and translational biomedical sciences. In 2012, he was appointed as a Research Instructor of Urology for his groundbreaking work in reprograming of stem cells by prostate cancer cells. In 2015, he has promoted to an Assistant Professor in the Department of Surgery at Tulane.
 

Research Interest

Our research focus is to unravel the molecular mechanisms underlying the regulatory role of exosomes-associated microRNAs in tumor progression of prostate cancer using tissue culture approach, animal model and human specimens. Prostate cancer comes second after lung cancer in men. Despite many genetic and epigenetic modifications are known, discovering new cellular mechanisms contributing to the disease progression will bring new “HOPE” for cancer patients. Also, how melanoma cells acquire drug resistance in patients harboring BRAF-V600E mutation is another area of interest. We consider engaging students and residents in research and establishing collaborations with other scientists and physicians are very important steps for building a strong research program in our department.
 

Leave Your Message 24x7
Top